Trial Profile

An open label, pilot, multicentre, stepdown, randomised controlled trial to examine whether etanercept 25mg once weekly is effective in maintaining a clinical response in patients with Ankylosing Spondylitis who have responded to 50mg once weekly.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database
06 Dec 2013 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
15 Nov 2012 Accrual to date is 118% according to United Kingdom Clinical Research Network.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com